GlassScriptPhysician profile
Brian Tobias
NPI 1720022692
$1,814.58
in general payments reported to CMS, 2019-2025
11 companies · $82.45 in 2025
The $82.45 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $149 · 2021: $25.84 · 2022: $189 · 2023: $1,183 · 2024: $185 · 2025: $82.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $786 · Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $785.61 |
| Food and Beverage | $664.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $1,150.04 | 2023 | Sx-One Microknife |
| Amgen INC. | $173.15 | 2024-2025 | Krystexxa |
| Acumed LLC | $149.49 | 2020 | |
| Integra Lifesciences Corporation | $123.05 | 2022 | |
| Stryker Corporation | $81.18 | 2024 | Hoffmann |
| Hydrocision, INC. | $41.45 | 2022 | |
| Horizon Therapeutics Plc | $32.85 | 2023 | Krystexxa |
| Orthofix Medical, INC. | $24.98 | 2022-2025 | Physio-Stim |
| Abbott Laboratories | $13.41 | 2021 | |
| Checkpoint Surgical, INC | $12.55 | 2022 | |
| Nevro Corp. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Tobias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.